Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20056114HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20056220HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20024007HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20039423HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS44008707HTLV-1ENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS44011238HTLV-1ENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS44033585HTLV-1ENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS44003748HTLV-1ENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS44018328HTLV-1ENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS44033529HTLV-1ENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TCGA Plot Options
Drug Information
GeneKCNJ6
DrugBank IDDB11633
Drug NameIsavuconazole
Target IDBE0001030
UniProt IDP48051
Regulation Typeinhibitor
PubMed IDs28074556
CitationsKeirns J, Desai A, Kowalski D, Lademacher C, Mujais S, Parker B, Schneidkraut MJ, Townsend R, Wojtkowski T, Yamazaki T, Yen M, Kowey PR: QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization. Clin Pharmacol Ther. 2017 Jun;101(6):782-790. doi: 10.1002/cpt.620. Epub 2017 Feb 13.
GroupsApproved; Investigational
Direct ClassificationPhenylpropanes
SMILESC[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Pathways
PharmGKB
ChEMBLCHEMBL409153